|
ES2228454T3
(es)
*
|
1999-02-26 |
2005-04-16 |
Chiron S.R.L. |
Mejora de la actividad bacteriana de antigenos de neisseria con oligonucleotidos que contienen motivos cg.
|
|
ES2330083T3
(es)
*
|
2000-10-27 |
2009-12-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
|
|
US7082569B2
(en)
|
2001-01-17 |
2006-07-25 |
Outlooksoft Corporation |
Systems and methods providing dynamic spreadsheet functionality
|
|
DK1858920T3
(en)
|
2005-02-18 |
2016-02-29 |
Glaxosmithkline Biolog Sa |
PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS / SEPSIS-ASSOCIATED ESCHERICHIA COLI
|
|
WO2007000341A2
(en)
|
2005-06-27 |
2007-01-04 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
EP2586790A3
(en)
|
2006-08-16 |
2013-08-14 |
Novartis AG |
Immunogens from uropathogenic Escherichia coli
|
|
ITMI20081249A1
(it)
*
|
2008-07-09 |
2010-01-09 |
Novartis Vaccines & Diagnostic |
Immunogeni di escherichia coli con solubilità migliorata.
|
|
JP5332237B2
(ja)
*
|
2008-03-06 |
2013-11-06 |
味の素株式会社 |
Ｌ−システイン生産菌及びｌ−システインの製造法
|
|
AU2009294318B2
(en)
|
2008-09-18 |
2014-04-24 |
Novartis Ag |
Vaccine adjuvant combinations
|
|
US8647642B2
(en)
|
2008-09-18 |
2014-02-11 |
Aviex Technologies, Llc |
Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
|
|
WO2010124085A2
(en)
*
|
2009-04-23 |
2010-10-28 |
Cornell University |
Compositions and methods for preventing and treating uterine disease
|
|
US9119802B2
(en)
*
|
2009-05-06 |
2015-09-01 |
Cornell University |
E. coli LpfA antigen for prevention and treatment of infectious diseases
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
WO2011008400A2
(en)
|
2009-06-16 |
2011-01-20 |
Novartis Ag |
High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
|
|
WO2011004263A2
(en)
|
2009-07-07 |
2011-01-13 |
Novartis Ag |
Conserved escherichia coli immunogens
|
|
PT2464658E
(pt)
|
2009-07-16 |
2015-01-14 |
Novartis Ag |
Imunogénios de escherichia coli desintoxicados
|
|
EP2277989A1
(en)
|
2009-07-24 |
2011-01-26 |
Technische Universiteit Delft |
Fermentative glycerol-free ethanol production
|
|
CN102740882A
(zh)
*
|
2009-08-27 |
2012-10-17 |
诺华有限公司 |
含有铝、寡核苷酸和聚阳离子的佐剂
|
|
MX2012002723A
(es)
|
2009-09-02 |
2012-04-11 |
Novartis Ag |
Composiciones inmunogenicas que incluyen moduladores de la actividad de receptores tipo toll.
|
|
ATE557035T1
(de)
*
|
2009-09-10 |
2012-05-15 |
Univ Berlin Freie |
Identifizierung und charakterisierung eines neuartigen aviären pathogenen e. coli (apec) fimbrien-adhäsins
|
|
DK2482836T3
(en)
*
|
2009-10-02 |
2016-06-06 |
Univ Oslo Hf |
Antibacterial polypeptides and the use thereof
|
|
US8741591B2
(en)
|
2009-10-09 |
2014-06-03 |
The Research Foundation For The State University Of New York |
pH-insensitive glucose indicator protein
|
|
WO2011069951A1
(en)
|
2009-12-11 |
2011-06-16 |
Glaxo Group Limited |
Imidazolidinedione derivatives
|
|
JP5781542B2
(ja)
*
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
EP2590626B1
(en)
|
2010-07-06 |
2015-10-28 |
GlaxoSmithKline Biologicals SA |
Liposomes with lipids having an advantageous pka-value for rna delivery
|
|
EP3243526B1
(en)
|
2010-07-06 |
2019-11-27 |
GlaxoSmithKline Biologicals S.A. |
Delivery of rna to trigger multiple immune pathways
|
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
|
PT2591114T
(pt)
|
2010-07-06 |
2016-08-02 |
Glaxosmithkline Biologicals Sa |
Imunização de mamíferos de grande porte com doses baixas de arn
|
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
|
HRP20161352T1
(hr)
|
2010-07-06 |
2016-12-02 |
Glaxosmithkline Biologicals Sa |
Čestice nalik na virione za unos samoreplicirajućih molekula rna
|
|
PL4066857T3
(pl)
|
2010-08-31 |
2023-03-20 |
Glaxosmithkline Biologicals Sa |
Pegylowane liposomy do dostarczania rna kodującego immunogen
|
|
CA2809863A1
(en)
|
2010-08-31 |
2012-03-08 |
Novartis Ag |
Lipids suitable for liposomal delivery of protein-coding rna
|
|
CN105999275A
(zh)
|
2010-09-01 |
2016-10-12 |
诺华有限公司 |
免疫增强剂吸附不溶性金属离子
|
|
BR112013005626B1
(pt)
|
2010-09-10 |
2022-07-26 |
Glaxosmithkline Biologicals Sa |
Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
|
|
CA2814386C
(en)
|
2010-10-11 |
2019-08-20 |
Novartis Ag |
Antigen delivery platforms
|
|
US9618508B2
(en)
|
2010-12-14 |
2017-04-11 |
Glaxosmithkline Biologicals Sa |
Flow cytometry analysis of materials adsorbed to metal salts
|
|
US10286056B2
(en)
|
2011-01-27 |
2019-05-14 |
Glaxosmithkline Biologicals S.A. |
Adjuvant nanoemulsions with crystallisation inhibitors
|
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US10687975B2
(en)
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US10111913B2
(en)
|
2011-02-04 |
2018-10-30 |
Joseph E. Kovarik |
Method of reducing the likelihood of skin cancer in an individual human being
|
|
US10085938B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for preventing sore throat in humans
|
|
US10835560B2
(en)
|
2013-12-20 |
2020-11-17 |
Joseph E. Kovarik |
Reducing the likelihood of skin cancer in an individual human being
|
|
US10010568B2
(en)
|
2011-02-04 |
2018-07-03 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a spirochetes infection in a human being
|
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US10086018B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US11357722B2
(en)
|
2011-02-04 |
2022-06-14 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
|
US9987224B2
(en)
|
2011-02-04 |
2018-06-05 |
Joseph E. Kovarik |
Method and system for preventing migraine headaches, cluster headaches and dizziness
|
|
US10548761B2
(en)
|
2011-02-04 |
2020-02-04 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
ES2681698T3
(es)
|
2011-03-02 |
2018-09-14 |
Glaxosmithkline Biologicals Sa |
Vacunas de combinación con menores dosis de antígeno y/o adyuvante
|
|
US10357568B2
(en)
|
2011-03-24 |
2019-07-23 |
Glaxosmithkline Biologicals S.A. |
Adjuvant nanoemulsions with phospholipids
|
|
CA2840989A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic combination compositions and uses thereof
|
|
CN103764121A
(zh)
|
2011-07-06 |
2014-04-30 |
诺华股份有限公司 |
用于递送rna分子的具有有用n:p比的脂质体
|
|
TR201900264T4
(tr)
|
2011-08-31 |
2019-02-21 |
Glaxosmithkline Biologicals Sa |
İmmünojen şifreleyici rna'nın verilmesi için pegile edilmiş lipozomlar.
|
|
EP2755994A2
(en)
|
2011-09-14 |
2014-07-23 |
Novartis AG |
Escherichia coli vaccine combination
|
|
KR101359844B1
(ko)
*
|
2012-01-06 |
2014-02-25 |
씨제이제일제당 (주) |
퀴놀린산을 생산하는 재조합 미생물 및 이를 이용한 퀴놀린산의 생산 방법
|
|
EP2806026B1
(en)
*
|
2012-01-18 |
2018-12-26 |
Mitsui Chemicals, Inc. |
Method for producing 1,5-pentamethylenediamine, mutant lysine decarboxylase, method for producing 1,5-pentamethylene diisocyanate and method for producing polyisocyanate composition
|
|
CN104519910B
(zh)
|
2012-03-07 |
2017-05-03 |
诺华股份有限公司 |
肺炎链球菌抗原的含佐剂制剂
|
|
CA2865759C
(en)
|
2012-03-07 |
2020-07-21 |
Novartis Ag |
Immunologically useful arginine salts
|
|
AU2013229432A1
(en)
|
2012-03-08 |
2014-10-16 |
Novartis Ag |
Adjuvanted formulations of booster vaccines
|
|
WO2014014207A1
(en)
*
|
2012-07-20 |
2014-01-23 |
University-Industry Cooperation Group Of Kyung Hee University |
Antibody for epitope tagging, hybridoma cell line and uses thereof
|
|
MX363529B
(es)
|
2012-09-18 |
2019-03-27 |
Novartis Ag |
Vesículas de membrana externa.
|
|
EP2909334B1
(en)
*
|
2012-10-17 |
2020-06-24 |
Enterome |
Gene signatures of inflammatory disorders that relate to the liver and to crohn's disease
|
|
US10288610B2
(en)
*
|
2012-11-13 |
2019-05-14 |
The General Hospital Corporation |
Vitro assays for detecting Salmonella enterica serotype typhi
|
|
WO2014102694A1
(en)
|
2012-12-24 |
2014-07-03 |
Novartis Ag |
Novel mucinase for use in therapy or prophylaxis
|
|
AU2014224205C1
(en)
|
2013-03-08 |
2019-04-04 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
EP2971041B1
(en)
|
2013-03-15 |
2018-11-28 |
The General Hospital Corporation |
Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
KR101525663B1
(ko)
*
|
2013-05-10 |
2015-06-04 |
씨제이제일제당 (주) |
신규 ｏ-포스포세린 배출 단백질 및 이를 이용한 ｏ-포스포세린의 생산방법
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
US10011850B2
(en)
|
2013-06-21 |
2018-07-03 |
The General Hospital Corporation |
Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
|
|
WO2015017280A1
(en)
*
|
2013-07-28 |
2015-02-05 |
Qantu Therapeutics, Inc. |
Vaccine formulations that induce a th2 immune response
|
|
KR20150018227A
(ko)
*
|
2013-08-09 |
2015-02-23 |
삼성전자주식회사 |
외인성 푸마라아제 유전자를 포함하는 코리네박테리움 및 이를 이용한 c4 디카르복실산의 생산 방법
|
|
US11248040B2
(en)
|
2013-09-26 |
2022-02-15 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
KR102523466B1
(ko)
|
2013-11-07 |
2023-04-20 |
에디타스 메디신, 인코포레이티드 |
지배적인 gRNA를 이용하는 CRISPR-관련 방법 및 조성물
|
|
US10426737B2
(en)
|
2013-12-19 |
2019-10-01 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
WO2015095340A1
(en)
|
2013-12-19 |
2015-06-25 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
|
US12318377B2
(en)
|
2013-12-20 |
2025-06-03 |
Seed Health, Inc. |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
WO2015134808A2
(en)
*
|
2014-03-06 |
2015-09-11 |
Research Institute At Nationwide Children's Hospital |
Probiotic formulations and methods for use
|
|
US10624934B2
(en)
*
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
|
CL2014001126A1
(es)
*
|
2014-04-29 |
2014-08-29 |
Univ Chile |
Composición farmacéutica útil como vacuna contra bacterias escherichia coli productoras de shigatoxinas (stec), que comprende al menos un antígeno o una proteína de membrana externa inmunogénica o proteína inmunogénica asociada y conservada en cepas stec.
|
|
ES2949172T3
(es)
|
2014-07-16 |
2023-09-26 |
Novartis Ag |
Método de encapsulamiento de un ácido nucleico en un hospedante de nanopartículas lipídicas
|
|
ES2969956T3
(es)
|
2014-09-05 |
2024-05-23 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
|
ES2811337T3
(es)
*
|
2015-04-07 |
2021-03-11 |
Metabolic Explorer Sa |
Microorganismo modificado para la producción optimizada de 2,4-dihidroxibutirato con eflujo de 2,4- dihidroxibutirato aumentado
|
|
US20160317615A1
(en)
*
|
2015-05-01 |
2016-11-03 |
Jose Javier Lopez GONZALEZ |
T cell modulator
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11209972B2
(en)
|
2015-09-02 |
2021-12-28 |
D&M Holdings, Inc. |
Combined tablet screen drag-and-drop interface
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
AU2016303688B2
(en)
|
2015-07-31 |
2023-06-15 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
EP3365027B1
(en)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu specific antibodies and their use in inhibiting biofilm
|
|
JP7016521B2
(ja)
*
|
2015-11-16 |
2022-02-07 |
国立大学法人 熊本大学 |
細胞の再プログラミングを誘導する組成物、及び該組成物を用いた多能性細胞の製造方法
|
|
US10568916B2
(en)
|
2015-11-30 |
2020-02-25 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US11529412B2
(en)
|
2015-11-30 |
2022-12-20 |
Seed Health, Inc. |
Method and system for protecting honey bees from pesticides
|
|
US10086024B2
(en)
|
2015-11-30 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US12239706B2
(en)
|
2015-11-30 |
2025-03-04 |
Seed Health, Inc. |
Method and system for protecting monarch butterflies from pesticides
|
|
US10675347B2
(en)
|
2015-11-30 |
2020-06-09 |
Joseph E. Kovarik |
Method and system for protecting honey bees from fipronil pesticides
|
|
US10933128B2
(en)
|
2015-11-30 |
2021-03-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees from pesticides
|
|
CA3011901A1
(en)
|
2016-01-21 |
2017-07-27 |
T2 Biosystems, Inc. |
Nmr methods and systems for the rapid detection of bacteria
|
|
EP3701964B1
(en)
*
|
2016-02-17 |
2023-11-08 |
Pepticom Ltd |
Peptide agonists and antagonists of tlr4 activation
|
|
WO2017160779A2
(en)
*
|
2016-03-14 |
2017-09-21 |
The Translational Genomics Research Institute |
Methods and kits to identify klebsiella strains
|
|
WO2017158135A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Dsm Ip Assets B.V. |
Microbial production of nicotinic acid riboside
|
|
JP6818871B2
(ja)
*
|
2016-04-27 |
2021-01-20 |
▲拝▼西欧斯（北京）生物技▲術▼有限公司 |
興奮性神経毒性に関連した損傷の治療用ペプチド
|
|
GB201617548D0
(en)
*
|
2016-10-17 |
2016-11-30 |
Linnane Pharma Ab |
Novel biological factor
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
WO2018126229A2
(en)
|
2016-12-30 |
2018-07-05 |
Sutrovax, Inc. |
Polypeptide-antigen conjugates with non-natural amino acids
|
|
WO2018129092A1
(en)
|
2017-01-04 |
2018-07-12 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Ｄｎａｂｉｉワクチンおよび強化された活性を有する抗体
|
|
AU2018260733B2
(en)
|
2017-04-28 |
2023-08-17 |
Bioverde Tech Llc |
Methods and microorganisms for the fermentation of methane to multi-carbon compounds
|
|
KR101943081B1
(ko)
*
|
2017-08-31 |
2019-01-29 |
(주)케어젠 |
주름 개선 활성을 나타내는 펩타이드 및 이의 용도
|
|
US20190233816A1
(en)
|
2018-01-26 |
2019-08-01 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
KR20210031933A
(ko)
|
2018-07-09 |
2021-03-23 |
코덱시스, 인코포레이티드 |
조작된 포스포펜토뮤타제 변이체 효소
|
|
US12150967B2
(en)
|
2018-08-18 |
2024-11-26 |
Seed Health, Inc. |
Methods and compositions for honey bee health
|
|
JP7541513B2
(ja)
*
|
2018-10-05 |
2024-08-28 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
細菌バイオフィルムの酵素的破壊のための組成物および方法
|
|
SG11202103001PA
(en)
|
2018-10-05 |
2021-04-29 |
Res Inst Nationwide Childrens Hospital |
Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
|
|
KR101991207B1
(ko)
|
2018-11-29 |
2019-06-19 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
KR101991206B1
(ko)
*
|
2018-11-29 |
2019-06-19 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
KR101996767B1
(ko)
*
|
2018-11-29 |
2019-07-04 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
JP7558167B2
(ja)
|
2018-12-03 |
2024-09-30 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
オリゴベンズアミド類似体およびがん処置におけるそれらの使用
|
|
BR112021011044A2
(pt)
*
|
2018-12-10 |
2021-08-31 |
Flagship Pioneering Innovations Vi, Llc |
Sistemas ativos dinâmicos acromossômicos
|
|
EP3984546A4
(en)
*
|
2019-05-15 |
2023-09-27 |
Universidad de Granada |
GENE THERAPY WITH THE HOKD AND LDRB GENES FOR CANCER TREATMENTS
|
|
CA3142272A1
(en)
|
2019-06-03 |
2020-12-10 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies
|
|
CA3139124C
(en)
*
|
2019-06-21 |
2023-01-31 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli
|
|
CN110441284B
(zh)
*
|
2019-07-23 |
2022-02-15 |
海南大学 |
一种可用于痕量检测的表面增强拉曼散射芯片的制备方法及所得产品和应用
|
|
KR102183209B1
(ko)
*
|
2019-09-09 |
2020-11-26 |
씨제이제일제당 주식회사 |
L-쓰레오닌 배출 단백질의 변이체 및 이를 이용한 l-쓰레오닌 생산 방법
|
|
EP4053287A4
(en)
*
|
2019-10-28 |
2023-11-01 |
Ajinomoto Co., Inc. |
Benzaldehyde production method
|
|
WO2021122528A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Basf Se |
Decreasing toxicity of terpenes and increasing the production potential in micro-organisms
|
|
US20230105474A1
(en)
*
|
2020-02-25 |
2023-04-06 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with uric acid and methods of use thereof
|
|
CN111778224B
(zh)
*
|
2020-07-20 |
2021-06-01 |
成都薇合生物科技有限公司 |
尿酸酶或其同源酶及其应用
|
|
US11767519B2
(en)
|
2020-08-28 |
2023-09-26 |
Codexis, Inc. |
Engineered amylase variants
|
|
JP2023544783A
(ja)
*
|
2020-10-07 |
2023-10-25 |
コデクシス， インコーポレイテッド |
操作されたホスホペントムターゼ改変体酵素
|
|
CN112391331B
(zh)
*
|
2020-11-12 |
2022-09-27 |
江南大学 |
一种过表达GatA基因的重组大肠杆菌及其应用
|
|
KR102792504B1
(ko)
*
|
2020-12-28 |
2025-04-09 |
대상 주식회사 |
히스티딘에 의한 피드백 억제가 감소된 atp-prt 변이체 및 이를 발현하는 히스티딘 생산 균주
|
|
CN114137209B
(zh)
*
|
2021-02-01 |
2024-03-01 |
中国水产科学研究院黄海水产研究所 |
一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用
|
|
US11452757B2
(en)
*
|
2021-02-25 |
2022-09-27 |
Intron Biotechnology, Inc. |
Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
|
|
CN117222427A
(zh)
*
|
2021-04-01 |
2023-12-12 |
杨森制药公司 |
大肠杆菌o18生物缀合物的生产
|
|
KR102707457B1
(ko)
*
|
2021-06-11 |
2024-09-20 |
씨제이제일제당 주식회사 |
신규한 MdtH 변이체 및 이를 이용한 O-포스포세린, 시스테인 및 이의 유도체의 생산방법
|
|
US20240350410A1
(en)
|
2021-08-16 |
2024-10-24 |
Glaxosmithkline Biologicals Sa |
Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof
|
|
WO2023021421A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Low-dose lyophilized rna vaccines and methods for preparing and using the same
|
|
US20250137050A1
(en)
*
|
2021-08-18 |
2025-05-01 |
The Regents Of The University Of California |
Methods and compositions for determining risk of autism spectrum disorders
|
|
CN113897324B
(zh)
*
|
2021-10-13 |
2023-07-28 |
云南师范大学 |
一种用作抗锰剂的JcVIPP1重组大肠杆菌及其构建方法
|
|
CN114107413B
(zh)
*
|
2021-11-03 |
2023-10-20 |
江苏香地化学有限公司 |
一种酶催化胞嘧啶生产胞苷的方法及应用
|
|
US11548917B1
(en)
*
|
2021-11-24 |
2023-01-10 |
Intron Biotechnology, Inc. |
Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
|
|
WO2023122632A1
(en)
*
|
2021-12-21 |
2023-06-29 |
Sri International |
Dual targeting for cell-specific delivery to the central nervous system
|
|
CN114522230A
(zh)
*
|
2022-01-11 |
2022-05-24 |
上海市伤骨科研究所 |
一种蓝光和对苯醌联合杀菌方法
|
|
WO2023139605A1
(en)
*
|
2022-01-20 |
2023-07-27 |
Techinvention Lifecare Pvt. Ltd. |
Lysin polypeptides and compositions thereof against urinary tract infection caused by drug-resistant gram- negative bacteria
|
|
CN115286701A
(zh)
*
|
2022-03-07 |
2022-11-04 |
江苏靶标生物医药研究所有限公司 |
一种调节哺乳动物的肠道粘膜稳态或炎症性肠病的靶点及其应用
|
|
US20240003886A1
(en)
*
|
2022-06-15 |
2024-01-04 |
Quantum-Si Incorporated |
Directed protein evolution
|
|
WO2024073730A2
(en)
*
|
2022-09-29 |
2024-04-04 |
The University Of Chicago |
Methods and systems for rna sequencing and analysis
|
|
AU2023362022A1
(en)
|
2022-10-19 |
2025-05-01 |
Glyprovac Aps |
Glycosylated yghj polypeptides from uropathogenic e. coli
|
|
CN118086235A
(zh)
*
|
2022-11-28 |
2024-05-28 |
宁波酶赛生物工程有限公司 |
一种合成d-泛解酸的酶催化剂和方法
|
|
KR20240120829A
(ko)
*
|
2023-01-31 |
2024-08-08 |
대상 주식회사 |
망가니즈 익스포터 신규 변이체 및 이를 이용한 l-히스티딘 생산 방법
|
|
GB202303019D0
(en)
|
2023-03-01 |
2023-04-12 |
Glaxosmithkline Biologicals Sa |
Method of lyophilisation
|
|
WO2025017339A1
(en)
*
|
2023-07-14 |
2025-01-23 |
Iowa State University Research Foundation, Inc. |
Escherichia coli nhaa membrane protein drug target and immunogenic compositions therefrom
|
|
CN116949027B
(zh)
*
|
2023-07-19 |
2024-12-24 |
浙江中医药大学 |
一种尿路致病性大肠埃希菌重组蛋白组合物ls、其构建、表达、纯化方法及其应用
|
|
GB202311382D0
(en)
|
2023-07-25 |
2023-09-06 |
Glaxosmithkline Biologicals Sa |
Lyophilised compostion
|
|
WO2025219177A1
(en)
|
2024-04-18 |
2025-10-23 |
Glyprovac Aps |
Optimized plasmids for expression of yghj polypeptides
|
|
CN118388664B
(zh)
*
|
2024-05-21 |
2024-12-03 |
广东省农业科学院动物卫生研究所 |
副猪嗜血杆菌融合抗原及其应用
|
|
CN119061031A
(zh)
*
|
2024-10-08 |
2024-12-03 |
安徽农业大学 |
一种水稻抗除草剂突变基因及其应用
|